VIDEO: Lexington Biosciences Founder: We Have a Cardiovascular Disease Prediction Device

May 30, 2018

Lexington Biosciences, Inc.’s (CSE:LNB) Donald McInnes discusses the Company’s regulatory and commercialization efforts

Lexington Biosciences Founder: We Have a Cardiovascular Disease Prediction Device

In an interview with SmallCapPower, Lexington Biosciences, Inc. (CSE:LNB) Founder and Board Advisor Donald McInnes explains that Lexington’s technology helps predict cardiovascular disease, which is known as the “silent killer.” Find out more about Lexington Biosciences’ regulatory and commercialization efforts by watching our interview with Donald McInnes.

SOURCE: https://smallcappower.com/videos/editors-pick-video/lexington-biosciences-stock/

Archives

Categories

Newsletter Updates

If you haven’t already done so, signup here to receive future editions and the latest company news direct to your inbox.

Latest News